Drugs / mepacaine
last change Oct 2024 re-read 2 minutes ago

mepacaine

Developed for
epicondylitis

Trials 0

Also used as a comparator or background therapy in 1 trial
PhaseRegistry idDatesIndicationSponsorStatusOutcome
NCT06710704 Comparator Apr → Oct 2024 epicondylitis Tanta University Completed No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as mepacaine ClinicalTrials.gov intervention name — accepted as the source's own label NCT06710704
Route Other “intraarticular injections of methylprednisolone (40 mg/ml) with 1 ml mepacaine” NCT06710704